Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Laser iridotomy.

P Richardson, R L Cooper

    Australian and New Zealand Journal of Ophthalmology
    |May 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Argon laser iridotomy effectively treats chronic angle-closure glaucoma. Patients without visual field loss had better outcomes, while 34% with field loss eventually needed trabeculectomy surgery.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    First Event-by-Event Identification of Cherenkov Radiation from Sub-Mev Particles in Liquid Argon.

    Physical review letters·2025
    Same author

    Retraction Note: SAR650984 directly induces multiple myeloma cell death via lysosomal-associated and apoptotic pathways, which is further enhanced by pomalidomide.

    Leukemia·2024
    Same author

    First Leptophobic Dark Matter Search from the Coherent-CAPTAIN-Mills Liquid Argon Detector.

    Physical review letters·2022
    Same author

    First Measurement of Coherent Elastic Neutrino-Nucleus Scattering on Argon.

    Physical review letters·2021
    Same author

    Safety and tolerability of injectable Rilpivirine LA in HPTN 076: A phase 2 HIV pre-exposure prophylaxis study in women.

    EClinicalMedicine·2020
    Same author

    First Measurement of the Total Neutron Cross Section on Argon between 100 and 800 MeV.

    Physical review letters·2019
    Same journal

    Thomas a'Beckett Travers, 1902-1999.

    Australian and New Zealand journal of ophthalmology·2000
    Same journal

    Bowen's disease of the eyelid in a renal transplant recipient on immunosuppressants.

    Australian and New Zealand journal of ophthalmology·2000
    Same journal

    Linear IgA disease.

    Australian and New Zealand journal of ophthalmology·2000
    Same journal

    Ring keratitis from topical anaesthetic misuse.

    Australian and New Zealand journal of ophthalmology·2000
    Same journal

    Lamellar corneal autograft for corneal perforation.

    Australian and New Zealand journal of ophthalmology·2000
    Same journal

    Preretinal haemorrhages: an unusual manifestation of intravitreal amikacin toxicity.

    Australian and New Zealand journal of ophthalmology·2000
    See all related articles

    Area of Science:

    • Ophthalmology
    • Laser Surgery
    • Glaucoma Management

    Background:

    • Chronic angle-closure glaucoma is a significant cause of vision loss.
    • Argon laser iridotomy is a common procedure for managing this condition.

    Purpose of the Study:

    • To evaluate the long-term effectiveness of argon laser iridotomy.
    • To identify factors influencing treatment outcomes in chronic angle-closure glaucoma patients.

    Main Methods:

    • Retrospective analysis of 64 consecutive argon laser iridotomy cases.
    • Mean follow-up period of 18 months.

    Main Results:

    • Argon laser iridotomy demonstrated effectiveness in treating chronic angle-closure glaucoma.
    • Patients without visual field loss experienced better outcomes compared to those with pre-existing field loss.

    Related Experiment Videos

  • 34% of patients with visual field loss ultimately required trabeculectomy.
  • Conclusions:

    • Argon laser iridotomy is an effective treatment for chronic angle-closure glaucoma.
    • Close patient follow-up post-iridotomy is crucial, especially for individuals with visual field loss.
    • Prognosis is poorer for patients with existing visual field deficits.